Value-based insurance design in medicare

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Applied Health Economics and Health Policy

• Publication date

  2009-09-01

• Fields of study

  Medicine, Business, Economics

• Identifiers
  DOI 10.2165/11318720-000000000-00000PMID 19799469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Take-up of Medicare Part D: results from the Health and Retirement Study.

  2010cited by this paper
• Limits on Medicare's ability to control rising spending on cancer drugs.

  2009cited by this paper
• Value-Based Insurance Design in the Medicare Prescription Drug Benefit: An Analysis of Policy Options

  2009cited by this paper
• Assessment of drug consumption patterns for Medicare Part D patients.

  2009cited by this paper
• Should drug prices be negotiated under part D of Medicare? And if so, how?

  2008cited by this paper
• Value-based insurance design.

  2007cited by this paper
• Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

  2007cited by this paper
• Substitution, Spending Offsets, and Prescription Drug Benefit Design

  2007cited by this paper
• Satisfaction guaranteed--"payment by results" for biologic agents.

  2007cited by this paper
• Patient Cost-Sharing, Hospitalization Offsets, and the Design of Optimal Health Insurance for the Elderly

  2007cited by this paper
• The first months of the prescription-drug benefit--a CMS update.

  2006cited by this paper
• Unintended consequences of caps on Medicare drug benefits.

  2006cited by this paper
• The effects of prescription drug cost sharing: a review of the evidence.

  2005cited by this paper
• How Does Cost-Sharing Affect Drug Purchases? Insurance Regimes in the Private Market for Prescription Drugs

  2004cited by this paper
• Book Review: The Impact of Cost-Sharing on Appropriate Utilization and Health Status: A Review of the Literature on Seniors

  2004cited by this paper
• Optimal Price Rules, Administered Prices and Suboptimal Prevention: Evidence from a Medicare Program

  2004cited by this paper
• Interventions to enhance patient adherence to medication prescriptions: scientific review.

  2002cited by this paper
• A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.

  2001cited by this paper
• Optimal health insurance: the case of observable, severe illness.

  2000cited by this paper
• Bonus options in health insurance.

  1992cited by this paper
• Patient Compliance in Medical Practice and Clinical Trials

  1991cited by this paper
• Noncompliance in Organ Transplant Recipients

  1991cited by this paper
• A radical prescription.

  1990cited by this paper
• Noncompliance in organ transplant recipients.

  1990cited by this paper
• Noncompliance in organ transplant recipients.

  1989cited by this paper

• Value-based insurance designs in the treatment of mental health disorders.

  2016cites this paper
• Medication adherence issues in patients: focus on cost

  2013cites this paper
• Availability and quality of data on drug policy and management of access to reimbursed medicinal products in the United Kingdom, Denmark, Germany, Italy and Poland

  2013cites this paper
• Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes.

  2012cites this paper